{"id":27229,"date":"2014-08-01T12:04:15","date_gmt":"2014-08-01T12:04:15","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=27229"},"modified":"2014-08-21T10:32:00","modified_gmt":"2014-08-21T10:32:00","slug":"community-reports-and-briefings-2","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/27229","title":{"rendered":"Community reports and briefings"},"content":{"rendered":"<h2>Report: 1st Hepatitis C Virus World CAB<\/h2>\n<p>This report is from the First Hepatitis C virus (HCV) World Community Advisory Board (CAB), held in Bangkok, Thailand, 22-25 February 2014.<\/p>\n<p>The objectives of the meeting were to:<\/p>\n<ul>\n<li>Provide a forum for leading activists to learn about developments in HCV treatment and access barriers<\/li>\n<li>Find common advocacy strategies<\/li>\n<li>Meet with pharmaceutical companies about their plans for low- and middle-income countries (LMICs).<\/li>\n<\/ul>\n<p>The HCV World CAB included a broad range of 38 activists from 22 countires, including people with HCV, people who inject drugs, HIV positive people, representatives from non-governmental organisations and regional and global advocacy networks, and clinicians and researchers.<\/p>\n<p>This was the first global meeting focused on HCV treatment access in low- and middle-income countires (LMIC) with pharmaceutical companies that produce HCV treatment.<\/p>\n<p>The meeting was organised by Treatment Action Group and the Asia Pacific Network of People Living with HIV\/AIDS. The HCV World CAB was supported by AIDS Fonds, the Global Network of People Living with HIV, M\u00e9decins du Monde, Open Society Foundations, and the World Health Organisation.<\/p>\n<p>The report is available in PDF format from Treatment Actiong Group website:<br \/>\n<a href=\"http:\/\/www.treatmentactiongroup.org\/hcv\/publications\/wcab-report-2014\">http:\/\/www.treatmentactiongroup.org\/hcv\/publications\/wcab-report-2014<\/a><\/p>\n<h2>RITA on HCV\/HIV coinfection: What HIV clinicians should know (and do) about HCV coinfection<\/h2>\n<p><a href=\"http:\/\/centerforaids.org\/pdfs\/0614ritafinal.pdf\">http:\/\/centerforaids.org\/pdfs\/0614ritafinal.pdf<\/a> (PDF)<\/p>\n<p>This issue of Research Initiative, Treatment Action (RITA) examines how direct-acting antivirals (DAAs) have already transformed treatment of HCV infection and considers how they may continue to do so. An interview with Douglas Dieterich offers nuts-and-bolts advice on prescribing DAAs for people with coinfection and encourages more involvement by HIV clinicians in HCV management.<\/p>\n<p>A second review article dissects the most controversial question about HCV\/HIV coinfection: does HCV make HIV infection worse? Scores of studies addressing different aspects of this question are almost evenly split in their conclusions.<\/p>\n<p>A final review analyses sexual HCV transmission among gay and bisexual men. Early research rated sexual HCV transmission a rare event. But that thinking &#8211; still echoed in some online US CDC material -stands starkly at odds with an explosive HCV epidemic documented in gay and bisexual people who do not inject drugs.<\/p>\n<h2>Migrant access to the NHS: implications of proposed changes<\/h2>\n<p>A briefing paper (March 2014) from the African Health Policy Network (AHPN) looks at the implications of the proposed NHS changes and whether this is justified by current evidence.<\/p>\n<p>For example, redefining the eligibility criteria of &#8220;ordinary resident&#8221; to mean &#8220;indefinite leave to remain&#8221; unfairly targets many long-term migrants who work, study and pay taxes that contribute to the running of NHS services as well as other public services.<\/p>\n<p><a href=\"http:\/\/www.ahpn.org\/\">http:\/\/www.ahpn.org\/<\/a><br \/>\n<a href=\"http:\/\/www.ahpn.org\/Uploa\/page\/155_Policy_Brief___Migrant_access_to_the_NHS_5.pdf\">http:\/\/www.ahpn.org\/Uploa\/page\/155_Policy_Brief___Migrant_access_to_the_NHS_5.pdf<\/a> (PDF)<\/p>\n<h2><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Report: 1st Hepatitis C Virus World CAB This report is from the First Hepatitis C virus (HCV) World Community Advisory Board (CAB), held in Bangkok, Thailand, 22-25 February 2014. The objectives of the meeting were to: Provide a forum for &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-27229","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/27229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=27229"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/27229\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=27229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=27229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=27229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}